News & Updates

How Motorcycle Drivers Are Transforming HIV Care and Treatment in Remote Areas of Tanzania

For years, residents of Muze village in the Sumbawanga District of Tanzania’s Rukwa Region have relied on a simple but powerful innovation: using local bodaboda (motorcycle) drivers to transport

Just a bug or the next big outbreak? U.S. CDC surveillance for influenza and other upper respiratory illness surveillance

Early detection through sentinel surveillance sample collection is critical for timely intervention and disease control. HJFMRI supports surveillance efforts designed primarily to detect influenza

Bridging the TB Diagnosis Gap: HJFMRI Rolls out Training on New Diagnostic Tool

In a landmark move to strengthen the fight against tuberculosis (TB) among people living with HIV (PLWH), this week HJF Medical Research International in collaboration with the Tanzanian MoH

Tackling Malnutrition: CHAMPS data to action leveraging locally available foods, training

Along the dirt roads deep inside Bar Agulu Village in Siaya County, freshly plowed farms are ready for planting season during the March to June rainy season. Several mango trees can be seen in almost

KASH Conference: HJFMRI supports and present scientific abstracts to advance health research

HJFMRI recently took part in the 15th KEMRI Annual Scientific and Health (KASH) Conference between February 11-15 in Nairobi, Kenya. This year's conference was grounded on the theme of Research

Joining Efforts to End HIV/AIDS in Kisumu

In Kisumu, we commemorated the World AIDS Day in collaboration with the National Syndemic Diseases Control Council (NSDCC) and other health implementing partners within the county. The event focused

Precision at Work - Inside the Defence Reference Laboratory’s Ancillary Calibration Laboratory

On the hills of Asokoro, Abuja, Nigeria, in a modest but bustling facility tucked away from public view, testing, precision, accuracy, traceability, and cost-efficiency are the pillars that define the

High hopes for the smallest patients: HJFMRI-supported surveillance research drives initiatives to reduce infant mortality in Kenya

The CHAMPS data to action program team conducted training for neonatal intensive care nurses on antenatal care approaches to improve outcomes for newborns.

US-Nigeria Partnership Bolsters Health Outcomes with the Commissioning of TB Modular Laboratory

In a significant advancement for Nigeria's public health infrastructure, the TB Modular Laboratory, located at the Defence Reference Laboratory in Mogadishu Cantonment, Abuja, was officially

HJFMRI Hosts Comprehensive Journalist Training for Effective HIV Response in Nigeria

The media plays a pivotal role in achieving the goal of ending the AIDS epidemic by 2030. By raising awareness, combating stigma, disseminating accurate information, promoting safe practices and

From Despair to Triumph: Charity’s Journey of Resilience and Empowerment

Charity’s life took an unexpected turn when she was taken from her village to Abuja, Nigeria’s bustling capital, by a relative who promised her a better life.

HJFMRI Supports the Launch of the Health Information System (HIS) within Tanzania Peoples Defence Forces (TPDF) Health Facilities

HJFMRI in collaboration with the Tanzania Peoples Defence Forces (TPDF) recently launched the Health Information System across health facilities within the TPDF

HJFMRI in Tanzania Recognized for Laboratory Strengthening

HJFMRI in Tanzania recently received an award from the Ministry of Health for their impactful effort supporting Walter Reed Army Institute of Research-Africa laboratory service enhancement initiatives

WRAIR Africa and MOD-HIP Organize Meeting to Enhance Health Services

On May 9-10, 2024, a gathering of esteemed health officials, military site commanders, and team leaders from the 31 program sites of the Ministry of Defence – Health Implementation Programme (MOD-HIP)

Participants in Nigeria vaccinated in first-ever Phase 2 Lassa fever vaccine clinical trial, sponsored by IAVI

Participants at HJF Medical Research International in Abuja, Nigeria, have been vaccinated in the first Phase 2 clinical trial of a Lassa fever virus (LASV) vaccine candidate to date, according to